StockData
Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc. (ARQT) stock

ARQTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30403% above fair value
$27.33+0.18 (+0.66%)

Close on Nov 17, 2026Market cap $3.44BP/E 124.2Yield –

Arcutis Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Arcutis Biotherapeutics's market cap was $3.56B on Nov 11, 2026, against $3.69B a year earlier. Over the last 5 years it ranged from $113.82M to $4.03B, with a median of $1.09B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.56B+2.0%
2025Dec 31, 2025$3.49B+114.3%
2024Dec 31, 2024$1.63B+715.7%
2023Dec 29, 2023$199.80M-77.8%
2022Dec 30, 2022$901.45M-13.3%
2021Dec 31, 2021$1.04B-2.2%
2020Dec 31, 2020$1.06B–

More Arcutis Biotherapeutics figures

See a number that looks wrong?